Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis
Molecular Biology Reports · 2026-12 · 53 (1)
DOI: 10.1007/s11033-026-12200-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 09.07.2026. Verfasst von Shariqa Jan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Srinagar-190005, Jammu, Srinagar, Kashmir, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tankyrases, beta Catenin, Neoplasm Proteins. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Srinagar-190005, Jammu, Srinagar, Kashmir, India.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
- Pediatric oncology, Oregon Health & Science University Hospital, 3181 SW Sam Jackson Park Rd, OR, 97239, Portland, USA.
- Division of Cancer Pharmacology, CSIR-Indian Institute of Integrative Medicine, Srinagar-190005, Jammu, Srinagar, Kashmir, India. fmalik@iiim.ac.in.
- Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. fmalik@iiim.ac.in.
Zitieren
APA
Jan, S., Fatima, K., Khan, S. U., & Malik, F. A. (2026). Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12200-3
Vancouver
Jan S, Fatima K, Khan SU, Malik FA. Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12200-3
BibTeX
@article{Jan2026,
author = {Jan, Shariqa and Fatima, Kaneez and Khan, Sameer Ullah and Malik, Fayaz A},
title = {Tankyrase inhibition restores chemosensitivity in triple-negative breast cancer cells by disrupting TFEB/β-Catenin/ABCG2 axis},
journal = {Molecular Biology Reports},
year = {2026},
volume = {53},
number = {1},
doi = {10.1007/s11033-026-12200-3}
}
EUVIMED